IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (NASDAQ:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three months ended March 31, 2017. “We are pleased with our progress during the quarter and our solid start to the year. Our top-line performance was driven by continued […]
Other News
Lombard Medical’s Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium
By Business Wire, May 04, 2017, 04:00:00 AM EDT OXFORDSHIRE, U.K.–(BUSINESS WIRE)– Lombard Medical, Inc. (NASDAQ:EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that its portfolio of endovascular stent graft systems, Altura® and Aorfix™, were featured in scientific presentations at the 39th annual Charing […]
Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (NASDAQ: CSII): Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal third quarter ended March 31, 2017. The company’s third-quarter revenues were $52.1 […]
Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2017
MARLBOROUGH, Mass., May 3, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced the schedule of key data presentations, including two late-breaking clinical trials, that will be featured at the 38th Annual Scientific Sessions of the Heart Rhythm Society in Chicago on May 10-13. Notably, the post-market approval data collected on […]
Medeon Biodesign Announces Approval to Begin CE Clinical Study
TAIPEI, Taiwan, May 2, 2017 /PRNewswire/ — Medeon Biodesign, Inc., a Taiwan publically traded medical device company, is pleased to announce today that it has received approval by the Health and Disability Ethics Committees, Ministry of Health, New Zealand to commence the CE clinical trial for the XProTM Suture-Mediated Vascular […]
Acutus Medical Snags FDA OK for AcQGuide Steerable Sheath
CARLSBAD, Calif.–(BUSINESS WIRE)–Acutus Medical®, a company committed to transforming the lives of millions of patients with complex arrhythmias, today announced the FDA clearance of the AcQGuide™ Steerable Sheath. The company will also feature several international presentations highlighting the AcQMap® High Resolution Imaging and Mapping System at the Heart Rhythm Society’s […]
LivaNova (LIVN) Takes Out Caisson Interventional in $72 Million Deal
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it has acquired the remaining outstanding interests in Caisson Interventional, LLC (“Caisson”), in support of LivaNova’s strategic growth initiatives. Based in Maple Grove, Minn., Caisson is a privately held clinical-stage medical device company focused on […]
Bay Area’s Outset Medical Banks $76.5 Million for Innovative Dialysis Technology
SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, a commercial-stage company delivering first-of-its-kind technology into the $13 billion global dialysis market, today announced $76.5 million in Series C equity funding. A new investor, funds advised by T. Rowe Price Associates, Inc., led the round, which also included participation from existing investors Fidelity Management […]
Biomerics to Create 380+ New Jobs in $38.5 Million HQ Expansion
Biomerics Announces New Corporate Headquarters SALT LAKE CITY, Utah, May 1, 2017 /PRNewswire-USNewswire/ — Biomerics, a leading medical device manufacturer for the cardiovascular market, announced today it will relocate to a new corporate headquarters in Salt Lake City, UT. The 230,000 square foot facility will be located in the International […]
Quanterix To Discuss Precision Cardiovascular Medicine At World Medical Innovation Forum
LEXINGTON, Mass.–(BUSINESS WIRE)–Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, today announced that Kevin Hrusovsky, CEO and Executive Chairman at Quanterix, will join a distinguished panel of industry experts to discuss the state and future of precision cardiovascular medicine at the World Medical Innovation […]



